Siegel R, Ward E, Brawley O, Jemal A: Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011, 61: 212–236. 10.3322/caac.20121
Article
PubMed
Google Scholar
Bokhman JV: Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983, 15: 10–17. 10.1016/0090-8258(83)90111-7
Article
CAS
PubMed
Google Scholar
Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I: Endometrial cancer. Lancet 2005, 366: 491–505. 10.1016/S0140-6736(05)67063-8
Article
PubMed
Google Scholar
Lee RC, Feinbaum RL, Ambros V: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75: 843–854. 10.1016/0092-8674(93)90529-Y
Article
CAS
PubMed
Google Scholar
Wightman B, Ha I, Ruvkun G: Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 1993, 75: 855–862. 10.1016/0092-8674(93)90530-4
Article
CAS
PubMed
Google Scholar
Gunaratne PH, Creighton CJ, Watson M, Tennakoon JB: Large-scale integration of MicroRNA and gene expression data for identification of enriched microRNA-mRNA associations in biological systems. Methods Mol Biol 2010, 667: 297–315. 10.1007/978-1-60761-811-9_20
Article
CAS
PubMed
Google Scholar
Brennecke J, Hipfner DR, Stark A, Russell RB, Cohen SM: bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 2003, 113: 25–36. 10.1016/S0092-8674(03)00231-9
Article
CAS
PubMed
Google Scholar
Chan JA, Krichevsky AM, Kosik KS: MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 2005, 65: 6029–6033. 10.1158/0008-5472.CAN-05-0137
Article
CAS
PubMed
Google Scholar
Ghodgaonkar MM, Shah RG, Kandan-Kulangara F, Affar EB, Qi HH, Wiemer E, Shah GM: Abrogation of DNA vector-based RNAi during apoptosis in mammalian cells due to caspase-mediated cleavage and inactivation of Dicer-1. Cell Death Differ 2009, 16: 858–868. 10.1038/cdd.2009.15
Article
CAS
PubMed
Google Scholar
Hwang HW, Mendell JT: MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 2006, 94: 776–780. 10.1038/sj.bjc.6603023
Article
CAS
PubMed Central
PubMed
Google Scholar
Tang F: Small RNAs in mammalian germline: Tiny for immorta. Differentiation 2010, 79: 141–146. 10.1016/j.diff.2009.11.002
Article
CAS
PubMed
Google Scholar
Navarro F, Lieberman J: Small RNAs guide hematopoietic cell differentiation and function. J Immunol 2010, 184: 5939–5947. 10.4049/jimmunol.0902567
Article
CAS
PubMed
Google Scholar
He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ, Hammond SM: A microRNA polycistron as a potential human oncogene. Nature 2005, 435: 828–833. 10.1038/nature03552
Article
CAS
PubMed
PubMed Central
Google Scholar
Johnson CD, Esquela-Kerscher A, Stefani G, Byrom M, Kelnar K, Ovcharenko D, Wilson M, Wang X, Shelton J, Shingara J: The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res 2007, 67: 7713–7722. 10.1158/0008-5472.CAN-07-1083
Article
CAS
PubMed
Google Scholar
Torres A, Torres K, Pesci A, Ceccaroni M, Paszkowski T, Cassandrini P, Zamboni G, Maciejewski R: Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients. Int J Cancer 2012. 10.1002/ijc.27840
Google Scholar
Karaayvaz M, Zhang C, Liang S, Shroyer KR, Ju J: Prognostic significance of miR-205 in endometrial cancer. PLoS One 2012, 7: e35158. 10.1371/journal.pone.0035158
Article
CAS
PubMed Central
PubMed
Google Scholar
Hiroki E, Akahira J, Suzuki F, Nagase S, Ito K, Suzuki T, Sasano H, Yaegashi N: Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas. Cancer Sci 2010, 101: 241–249. 10.1111/j.1349-7006.2009.01385.x
Article
CAS
PubMed
Google Scholar
Gu J, Wang Y, Wu X: MicroRNA in the Pathogenesis and Prognosis of Esophageal Cancer. Curr Pharm Des 2013,19(7):1292–300. 10.2174/138161213804805775
CAS
PubMed
Google Scholar
Mees ST, Mardin WA, Wendel C, Baeumer N, Willscher E, Senninger N, Schleicher C, Colombo-Benkmann M, Haier J: EP300–a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas. Int J Cancer 2010, 126: 114–124. 10.1002/ijc.24695
Article
CAS
PubMed
Google Scholar
Meng Z, Fu X, Chen X, Zeng S, Tian Y, Jove R, Xu R, Huang W: miR-194 is a marker of hepatic epithelial cells and suppresses metastasis of liver cancer cells in mice. Hepatology 2010, 52: 2148–2157. 10.1002/hep.23915
Article
CAS
PubMed Central
PubMed
Google Scholar
Kahlert C, Klupp F, Brand K, Lasitschka F, Diederichs S, Kirchberg J, Rahbari N, Dutta S, Bork U, Fritzmann J: Invasion front-specific expression and prognostic significance of microRNA in colorectal liver metastases. Cancer Sci 2011, 102: 1799–1807. 10.1111/j.1349-7006.2011.02023.x
Article
CAS
PubMed
Google Scholar
Chiang Y, Song Y, Wang Z, Liu Z, Gao P, Liang J, Zhu J, Xing C, Xu H: microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer. Exp Ther Med 2012, 3: 560–566.
CAS
PubMed Central
PubMed
Google Scholar
Senanayake U, Das S, Vesely P, Alzoughbi W, Frohlich LF, Chowdhury P, Leuschner I, Hoefler G, Guertl B: miR-192, miR-194, miR-215, miR-200c and miR-141 are downregulated and their common target ACVR2B is strongly expressed in renal childhood neoplasms. Carcinogenesis 2012, 33: 1014–1021. 10.1093/carcin/bgs126
Article
CAS
PubMed
Google Scholar
Sundaram P, Hultine S, Smith LM, Dews M, Fox JL, Biyashev D, Schelter JM, Huang Q, Cleary MA, Volpert OV, Thomas-Tikhonenko A: p53-responsive miR-194 inhibits thrombospondin-1 and promotes angiogenesis in colon cancers. Cancer Res 2011, 71: 7490–7501. 10.1158/0008-5472.CAN-11-1124
Article
CAS
PubMed Central
PubMed
Google Scholar
Le XF, Almeida MI, Mao W, Spizzo R, Rossi S, Nicoloso MS, Zhang S, Wu Y, Calin GA, Bast RC Jr: Modulation of MicroRNA-194 and cell migration by HER2-targeting trastuzumab in breast cancer. PLoS One 2012, 7: e41170. 10.1371/journal.pone.0041170
Article
CAS
PubMed Central
PubMed
Google Scholar
Dong P, Kaneuchi M, Watari H, Hamada J, Sudo S, Ju J, Sakuragi N: MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1. Mol Cancer 2011, 10: 99. 10.1186/1476-4598-10-99
Article
CAS
PubMed Central
PubMed
Google Scholar
Colas E, Pedrola N, Devis L, Ertekin T, Campoy I, Martinez E, Llaurado M, Rigau M, Olivan M, Garcia M: The EMT signaling pathways in endometrial carcinoma. Clin Transl Oncol 2012, 14: 715–720. 10.1007/s12094-012-0866-3
Article
CAS
PubMed
Google Scholar
Vonlanthen S, Heighway J, Altermatt HJ, Gugger M, Kappeler A, Borner MM, van Lohuizen M, Betticher DC: The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression. Br J Cancer 2001, 84: 1372–1376. 10.1054/bjoc.2001.1791
Article
CAS
PubMed Central
PubMed
Google Scholar
Guo BH, Feng Y, Zhang R, Xu LH, Li MZ, Kung HF, Song LB, Zeng MS: Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer. Mol Cancer 2011, 10: 10. 10.1186/1476-4598-10-10
Article
CAS
PubMed Central
PubMed
Google Scholar
Glinsky GV, Berezovska O, Glinskii AB: Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest 2005, 115: 1503–1521. 10.1172/JCI23412
Article
CAS
PubMed Central
PubMed
Google Scholar
Zhang FB, Sui LH, Xin T: Correlation of Bmi-1 expression and telomerase activity in human ovarian cancer. Br J Biomed Sci 2008, 65: 172–177.
CAS
PubMed
Google Scholar
Honig A, Weidler C, Hausler S, Krockenberger M, Buchholz S, Koster F, Segerer SE, Dietl J, Engel JB: Overexpression of polycomb protein BMI-1 in human specimens of breast, ovarian, endometrial and cervical cancer. Anticancer Res 2010, 30: 1559–1564.
CAS
PubMed
Google Scholar
Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA: MicroRNA expression profiles classify human cancers. Nature 2005, 435: 834–838. 10.1038/nature03702
Article
CAS
PubMed
Google Scholar
Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006, 103: 2257–2261. 10.1073/pnas.0510565103
Article
CAS
PubMed Central
PubMed
Google Scholar
Karaayvaz M, Pal T, Song B, Zhang C, Georgakopoulos P, Mehmood S, Burke S, Shroyer K, Ju J: Prognostic Significance of miR-215 in Colon Cancer. Clin Colorectal Cancer 2011, 10: 340–347. 10.1016/j.clcc.2011.06.002
Article
CAS
PubMed Central
PubMed
Google Scholar
Xi Y, Nakajima G, Gavin E, Morris CG, Kudo K, Hayashi K, Ju J: Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. RNA 2007, 13: 1668–1674. 10.1261/rna.642907
Article
CAS
PubMed Central
PubMed
Google Scholar
Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008, 105: 10513–10518. 10.1073/pnas.0804549105
Article
CAS
PubMed Central
PubMed
Google Scholar